UFP Technologies, Inc. Revenue from Contract with Customer, Including Assessed Tax
UFP Technologies, Inc. (UFPT) reported Revenue from Contract with Customer, Including Assessed Tax of $151.18 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-11.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2025-08-11
- UFP Technologies, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2025-06-30 was $151.18M, a 37.21% increase year-over-year.
- UFP Technologies, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2025-03-31 was $148.15M, a 41.08% increase year-over-year.
- UFP Technologies, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2024-12-31 was $144.07M, a 41.94% increase year-over-year.
- UFP Technologies, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2024-09-30 was $145.16M, a 44.04% increase year-over-year.
- UFP Technologies, Inc. revenue from contract with customer, including assessed tax for fiscal 2024 was $504.42M, a 26.08% increase from fiscal 2023.
- UFP Technologies, Inc. revenue from contract with customer, including assessed tax for fiscal 2023 was $400.07M, a 13.08% increase from fiscal 2022.
- UFP Technologies, Inc. revenue from contract with customer, including assessed tax for fiscal 2022 was $353.79M, a 71.48% increase from fiscal 2021.
- UFP Technologies, Inc. revenue from contract with customer, including assessed tax for fiscal 2021 was $206.32M, a 15.02% increase from fiscal 2020.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|---|---|
| 2025-06-30 | $151.18M 10-Q · filed 2025-08-11 | $299.32M 10-Q · filed 2025-08-11 | $443.39M derived: sum of 3 quarters · filed 2025-08-11 | $588.56M derived: sum of 4 quarters · filed 2025-08-11 |
| 2025-03-31 | $148.15M 10-Q · filed 2025-05-12 | $292.22M derived: sum of 2 quarters · filed 2025-05-12 | $437.38M derived: sum of 3 quarters · filed 2025-05-12 | $547.56M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-12-31 | $144.07M 10-K · filed 2025-03-03 | $289.24M derived: sum of 2 quarters · filed 2025-03-03 | $399.41M derived: sum of 3 quarters · filed 2025-08-11 | $504.42M 10-K · filed 2025-03-03 |
| 2024-09-30 | $145.16M 10-K · filed 2025-03-03 | $255.34M derived: sum of 2 quarters · filed 2025-08-11 | $360.35M 10-Q · filed 2024-11-12 | $461.85M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-06-30 | $110.18M 10-Q · filed 2025-08-11 | $215.19M 10-Q · filed 2025-08-11 | $316.68M derived: sum of 3 quarters · filed 2025-08-11 | $417.47M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $105.01M 10-Q · filed 2025-05-12 | $206.51M derived: sum of 2 quarters · filed 2025-05-12 | $307.29M derived: sum of 3 quarters · filed 2025-05-12 | $407.33M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $101.50M 10-K · filed 2025-03-03 | $202.28M derived: sum of 2 quarters · filed 2025-03-03 | $302.32M derived: sum of 3 quarters · filed 2025-03-03 | $400.07M 10-K · filed 2025-03-03 |
| 2023-09-30 | $100.78M 10-K · filed 2025-03-03 | $200.82M derived: sum of 2 quarters · filed 2025-03-03 | $298.57M 10-Q · filed 2024-11-12 | $389.81M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $100.04M 10-K · filed 2025-03-03 | $197.79M 10-Q · filed 2024-08-09 | $289.03M derived: sum of 3 quarters · filed 2025-03-03 | $386.00M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $97.75M 10-K · filed 2025-03-03 | $188.99M derived: sum of 2 quarters · filed 2025-03-03 | $285.96M derived: sum of 3 quarters · filed 2025-03-03 | $380.30M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $91.24M 10-K · filed 2025-03-03 | $188.21M derived: sum of 2 quarters · filed 2025-03-03 | $282.55M derived: sum of 3 quarters · filed 2025-03-03 | $353.79M 10-K · filed 2025-03-03 |
| 2022-09-30 | $96.97M 10-K · filed 2025-03-03 | $191.31M derived: sum of 2 quarters · filed 2025-03-03 | $262.56M 10-Q · filed 2023-11-09 | $318.90M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-06-30 | $94.34M 10-K · filed 2025-03-03 | $165.59M 10-Q · filed 2023-08-09 | $221.93M derived: sum of 3 quarters · filed 2025-03-03 | $272.65M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-03-31 | $71.24M 10-K · filed 2025-03-03 | $127.58M derived: sum of 2 quarters · filed 2025-03-03 | $178.31M derived: sum of 3 quarters · filed 2025-03-03 | $228.96M derived: sum of 4 quarters · filed 2025-03-03 |
| 2021-12-31 | $56.34M 10-K · filed 2023-03-16 | $107.07M derived: sum of 2 quarters · filed 2023-03-16 | $157.72M derived: sum of 3 quarters · filed 2023-03-16 | $206.32M 10-K · filed 2024-02-29 |
| 2021-09-30 | $50.72M 10-K · filed 2023-03-16 | $101.38M derived: sum of 2 quarters · filed 2023-03-16 | $149.98M 10-Q/A · filed 2022-11-14 | $195.13M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | $50.66M 10-K · filed 2023-03-16 | $99.25M 10-Q · filed 2022-08-09 | $144.41M derived: sum of 3 quarters · filed 2023-03-16 | $187.71M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-03-31 | $48.60M 10-K · filed 2023-03-16 | $93.75M derived: sum of 2 quarters · filed 2023-03-16 | $137.05M derived: sum of 3 quarters · filed 2023-03-16 | $179.69M derived: sum of 4 quarters · filed 2023-03-16 |
| 2020-12-31 | $45.15M 10-K · filed 2022-03-14 | $88.45M derived: sum of 2 quarters · filed 2022-03-14 | $131.10M derived: sum of 3 quarters · filed 2022-03-14 | $179.37M 10-K · filed 2023-03-16 |
| 2020-09-30 | $43.30M 10-K · filed 2022-03-14 | $85.94M derived: sum of 2 quarters · filed 2022-03-14 | $134.22M 10-Q · filed 2021-11-05 | $184.48M derived: sum of 4 quarters · filed 2022-03-14 |
| 2020-06-30 | $42.64M 10-K · filed 2022-03-14 | $90.92M 10-Q · filed 2021-08-06 | $141.18M derived: sum of 3 quarters · filed 2022-03-14 | $190.57M derived: sum of 4 quarters · filed 2022-03-14 |
| 2020-03-31 | $48.28M 10-K · filed 2022-03-14 | $98.54M derived: sum of 2 quarters · filed 2022-03-14 | $147.93M derived: sum of 3 quarters · filed 2022-03-14 | $199.33M derived: sum of 4 quarters · filed 2022-03-14 |
| 2019-12-31 | $50.26M 10-K · filed 2021-03-12 | $99.65M derived: sum of 2 quarters · filed 2021-03-12 | $151.05M derived: sum of 3 quarters · filed 2021-03-12 | $198.38M 10-K · filed 2022-03-14 |
| 2019-09-30 | $49.39M 10-K · filed 2021-03-12 | $100.79M derived: sum of 2 quarters · filed 2021-03-12 | $148.12M 10-Q · filed 2020-11-06 | $198.82M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $51.40M 10-K · filed 2021-03-12 | $98.73M 10-Q · filed 2020-08-07 | $149.42M derived: sum of 3 quarters · filed 2021-03-12 | $197.23M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | $47.33M 10-K · filed 2021-03-12 | $98.03M derived: sum of 2 quarters · filed 2021-03-12 | $145.83M derived: sum of 3 quarters · filed 2021-03-12 | $194.85M derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $50.70M 10-K · filed 2020-03-13 | $98.50M derived: sum of 2 quarters · filed 2020-03-13 | $147.52M derived: sum of 3 quarters · filed 2020-03-13 | $190.46M 10-K · filed 2021-03-12 |
| 2018-09-30 | $47.81M 10-K · filed 2020-03-13 | $96.83M derived: sum of 2 quarters · filed 2020-03-13 | $139.76M 10-Q · filed 2019-11-08 | $176.98M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-06-30 | $49.02M 10-K · filed 2020-03-13 | $91.95M 10-Q · filed 2019-08-09 | $129.17M derived: sum of 3 quarters · filed 2020-03-13 | $164.85M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-03-31 | $42.93M 10-K · filed 2020-03-13 | $80.15M derived: sum of 2 quarters · filed 2020-03-13 | $115.83M derived: sum of 3 quarters · filed 2020-03-13 | $153.72M derived: sum of 4 quarters · filed 2020-03-13 |
| 2017-12-31 | $37.22M 10-K · filed 2019-03-15 | $72.90M derived: sum of 2 quarters · filed 2019-03-15 | $110.79M derived: sum of 3 quarters · filed 2019-03-15 | $147.84M 10-K · filed 2020-03-13 |
| 2017-09-30 | $35.68M 10-K · filed 2019-03-15 | $73.57M derived: sum of 2 quarters · filed 2019-03-15 | $110.62M 10-Q · filed 2018-11-09 | |
| 2017-06-30 | $37.89M 10-K · filed 2019-03-15 | $74.94M 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $37.05M 10-K · filed 2019-03-15 | |||
| 2016-12-31 | $146.13M 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |